Drug Database · Clinicians

Metformin

Brands (143) Glumet, Glucophage XR, Glyformet…Show all
Glumet · Glucophage XR · Glyformet · Humamet · Diabemin XR · Gludin · Metfn · Metfor XR · Nifromin · Nimrof · Rafor · Sugartrol · Thormin · Aartmin 850 · Diafat · Euformin · Fored · Formigen · Fornidd XR · Glucosil · Glucotin · Glumet-XR · Glycemet · Maximet · Metfored · Neoform® 500 · Theomet-500 · Aceformin · Azfor · Beramet · Bigsens XR 750 · Bliformin-500 · Chemophase-500 · Diabase · Diamet · Diamet 500 · Diavin 500 XR · Dimet-850 · DMphage ER 500 · Emnorm ER 500 · Etromin 1000 · Etromin 500 · Etromin 850 · Forherdin · Formet · Formet 500 · Formetin · Formex · Formigen 1000 · Formigen 500 · Formigen 850 · Fornidd · Gluceemin · Glucoform · Glucomin · Glucophage · Glucophage Forte · Glucosaph-GE850 · Glucostop · Gludin XR · Gluko-S · Glumira · Gluventa PR 1000 · Gluventa PR 500 · Gluventa PR 750 · GLYCELIFE · Glycemed 1000 · Glycemed 500 · Glycemed 750 · Glycemin · Glycemin SR · Glyminov 500 · Glymora · Glyvexamed · GMet 1000 · GMet 500 · Goformin · Hexamet · Hexamin SR · HovidEuform · HovidEuform XR · I-Max · Lifemet · Meclormin · Medformin-500 · Medglu · Meforin · Melfor · Melmet SR 1000 · Melmet SR 500 · Melmet-850 · Met-A-Day · Metagold · Metcore · Metfor PR 1000. · Metformix · Metforze · Metokon · Metoxed · Metpen-850 · Metpro-1000 · Metrol · Metromet · Metstan · Metsure · Metta SR · Metter · Metxr 1000 · Metxr 500 · Metzan 850 · Metzan-500 · Metzen · Mymet · Nanomet · Neomet · Nevox XR · Nidcor · Norglumin · Normax · Obimet 500 · Panfor Pr-500 · Panfor SR-1000 · Panfor SR-500 · Philmet-500 · Proglutrol 1000 · Proglutrol 500 · Reform · Regimet · Sheformin · Splendamet · Sucranorm · Sucrol · Sugadrop · Sugargone · Sukrivent 1000 · Sukrivent 500 · Switles · Technomet · Vimetrol · Xmet ER 500 · Xomet · Xrmin ER 1000. · Xrmin ER 500

US brand (reference label): METFORMIN HYDROCHLORIDE; not a Philippine-registered brand.

Oral hypoglycemic agent (biguanide); Oral hypoglycemic (biguanide); and others PH FDA category

Contraindicated if eGFR <30Rx · Prescription drug243 PH productsPNF-listedPhilHealth GAMOTVAT-exempt (some products) Kidney dosing reviewed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 4e4c4ba9-65c6-4273-8f6b-2423ab521dad, version date August 21, 2026 (METFORMIN HYDROCHLORIDE · ScieGen Pharmaceuticals Inc). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • Metformin Hydrochloride Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.
US FDA label
Full indications and usage US FDA label

1 INDICATIONS AND USAGE Metformin Hydrochloride Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. Metformin is a biguanide indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. (1)

Contraindications

  • Severe kidney impairment (eGFR below 30 mL/min/1.73 m2)
  • Hypersensitivity to metformin
  • Acute or chronic metabolic acidosis, including diabetic ketoacidosis
renalcarematters.com, reviewed
Contraindications (US label) US FDA label

4 CONTRAINDICATIONS Metformin Hydrochloride Tablets are contraindicated in patients with: Severe renal impairment (eGFR below 30 mL/min/1.73 m²) [see Warnings and Precautions (5.1)]. Hypersensitivity to metformin. Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. Severe renal impairment (eGFR below 30 mL/min/1.73 m²) (4, 5.1) Hypersensitivity to metformin (4) Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma.(4)

Dosing: Adult

  • Type 2 diabetes (immediate-release tablets): Start 500 mg twice daily or 850 mg once daily with meals; increase by 500 mg weekly or 850 mg every 2 weeks; maximum 2,550 mg/day in divided doses (doses above 2,000 mg may be better tolerated three times daily)
  • Type 2 diabetes (extended-release products): Follow the product's own label (the Glumetza US label: start 500 mg once daily with the evening meal, maximum 2,000 mg once daily)
renalcarematters.com, reviewed
Dosage and administration (US label) US FDA label
  • Adult Dosage for Metformin Hydrochloride Tablets: Starting dose: 500 mg orally twice a day or 850 mg once a day, with meals (2.1)
  • Increase the dose in increments of 500 mg weekly or 850 mg every 2 weeks, up to a maximum dose of 2550 mg per day, given in divided doses (2.1)
  • Doses above 2000 mg may be better tolerated given 3 times a day with meals (2.1)
  • Pediatric Dosage for Metformin Hydrochloride Tablets: Starting dose: 500 mg orally twice a day, with meals (2.2)
  • Increase dosage in increments of 500 mg weekly up to a maximum of 2000 mg per day, given in divided doses twice daily (2.2)
  • Renal Impairment: Prior to initiation, assess renal function with estimated glomerular filtration rate (eGFR) (2.3)
  • Do not use in patients with eGFR below 30 mL/minute/1.73 m² (2.3)
  • Initiation is not recommended in patients with eGFR between 30-45 mL/minute/1.73 m² (2.3)
  • Assess risk/benefit of continuing if eGFR falls below 45 mL/minute/1.73 m² (2.3)
  • Discontinue if eGFR falls below 30 mL/minute/1.73 m² (2.3)
  • Discontinuation for Iodinated Contrast Imaging Procedures: Metformin Hydrochloride Tablets may need to be discontinued at time of, or prior to, iodinated contrast imaging procedures (2.4)
2.1 Adult Dosage

2.1 Adult Dosage Metformin Hydrochloride Tablets The recommended starting dose of Metformin Hydrochloride Tablets is 500 mg orally twice a day or 850 mg once a day, given with meals. Increase the dose in increments of 500 mg weekly or 850 mg every 2 weeks on the basis of glycemic control and tolerability, up to a maximum dose of 2550 mg per day, given in divided doses.

Doses above 2000 mg may be better tolerated given 3 times a day with meals.

2.2 Pediatric Dosage for Metformin Hydrochloride Tablets

2.2 Pediatric Dosage for Metformin Hydrochloride Tablets The recommended starting dose of Metformin Hydrochloride Tablets for pediatric patients 10 years of age and older is 500 mg orally twice a day, given with meals. Increase dosage in increments of 500 mg weekly on the basis of glycemic control and tolerability, up to a maximum of 2000 mg per day, given in divided doses twice daily.

2.3 Recommendations for Use in Renal Impairment

2.3 Recommendations for Use in Renal Impairment Assess renal function prior to initiation of Metformin Hydrochloride Tablets and periodically thereafter. Metformin Hydrochloride Tablets are contraindicated in patients with an estimated glomerular filtration rate (eGFR) below 30 mL/minute/1.73 m². Initiation of Metformin Hydrochloride Tablets in patients with an eGFR between 30 – 45 mL/minute/1.73 m² is not recommended.

In patients taking Metformin Hydrochloride Tablets whose eGFR later falls below 45 mL/min/1.73 m², assess the benefit risk of continuing therapy. Discontinue Metformin Hydrochloride Tablets if the patient’s eGFR later falls below 30 mL/minute/1.73 m² [see Warnings and Precautions (5.1)].

2.4 Discontinuation for Iodinated Contrast Imaging Procedures

2.4 Discontinuation for Iodinated Contrast Imaging Procedures Discontinue Metformin Hydrochloride Tablets at the time of, or prior to, an iodinated contrast imaging procedure in patients with an eGFR between 30 and 60 mL/min/1.73 m²; in patients with a history of liver disease, alcoholism, or heart failure; or in patients who will be administered intra-arterial iodinated contrast. Re-evaluate eGFR 48 hours after the imaging procedure; restart Metformin Hydrochloride Tablets if renal function is stable.

Dosing: Altered kidney function

Metformin is cleared by the kidneys, and the risk of lactic acidosis rises as kidney function falls. The US label contraindicates it below an estimated glomerular filtration rate (eGFR) of 30 mL/min/1.73 m2 and advises against starting it at eGFR 30 to 45; guidelines cap the dose at 1,000 mg/day if it is continued at eGFR 30 to 44.

Kidney function measure: Label uses eGFR (mL/min/1.73 m2).

Show full dosing details
eGFR ≥60
Usual dosing. Assess kidney function before starting and periodically (label).
eGFR 30–59
eGFR 45–59: usual dose; consider dose reduction if at high risk of lactic acidosis. eGFR 30–44: label advises not to start; if continuing, reduce to a maximum of 1,000 mg/day (KDIGO 2022; ADA-KDIGO 2022). Recheck eGFR every 3 to 6 months.
eGFR 15–29
Contraindicated (label). Stop if eGFR falls below 30.
eGFR <15 (not on dialysis)
Contraindicated (label).
Hemodialysis (intermittent)
Contraindicated (eGFR <30 per label).
Peritoneal dialysis
Contraindicated (eGFR <30 per label).
CRRT
Not appropriate; contraindicated in severe kidney impairment (label).
  • Dialyzable? Yes: dialyzable with clearance up to 170 mL/min under good hemodynamic conditions; hemodialysis may help remove drug in suspected overdose (label).
  • Monitoring eGFR before starting and at least periodically; more often in older adults. Stop before or at the time of iodinated contrast in at-risk patients per label. Hold temporarily during acute illness with dehydration, sepsis, hypoxia or acute heart failure, during procedures with restricted food or fluid intake, and for acute kidney injury; restart when eating and kidney function is stable (label 5.1).
Children (kidney dosing)
Show full dosing details
eGFR ≥60
Immediate-release, 10 years and older: start 500 mg twice daily (label).
eGFR 30–59
As for adults: eGFR 45–59 usual dose with monitoring; eGFR 30–44 do not start, and if continuing use a maximum of 1,000 mg/day (KDIGO 2022; ADA-KDIGO 2022).
eGFR 15–29
Contraindicated (label contraindication at eGFR <30 applies to all patients).
eGFR <15 (not on dialysis)
Contraindicated (eGFR <30).
Hemodialysis (intermittent)
Contraindicated.
Peritoneal dialysis
Contraindicated.
CRRT
Not appropriate.

Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.

renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 16, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.

US label text: Renal impairment US FDA label

2.3 Recommendations for Use in Renal Impairment Assess renal function prior to initiation of Metformin Hydrochloride Tablets and periodically thereafter. Metformin Hydrochloride Tablets are contraindicated in patients with an estimated glomerular filtration rate (eGFR) below 30 mL/minute/1.73 m². Initiation of Metformin Hydrochloride Tablets in patients with an eGFR between 30 – 45 mL/minute/1.73 m² is not recommended.

In patients taking Metformin Hydrochloride Tablets whose eGFR later falls below 45 mL/min/1.73 m², assess the benefit risk of continuing therapy. Discontinue Metformin Hydrochloride Tablets if the patient’s eGFR later falls below 30 mL/minute/1.73 m² [see Warnings and Precautions (5.1)].

8.6 Renal Impairment Metformin is substantially excreted by the kidney, and the risk of metformin accumulation and lactic acidosis increases with the degree of renal impairment. Metformin Hydrochloride is contraindicated in severe renal impairment, patients with an estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m² [see Dosage and Administration (2.3), Contraindications (4), Warnings and Precautions (5.1), and Clinical Pharmacology (12.3)].

Renal Impairment In patients with decreased renal function the plasma and blood half-life of metformin is prolonged and the renal clearance is decreased (see Table 3) [See Dosage and Administration (2.3), Contraindications (4), Warnings and Precautions (5.1) and Use in Specific Populations (8.6)].

Dosing: Hepatic impairment

8.7 Hepatic Impairment Use of metformin in patients with hepatic impairment has been associated with some cases of lactic acidosis. Metformin Hydrochloride is not recommended in patients with hepatic impairment. [see Warnings and Precautions (5.1)].

US FDA label

Dosing: Pediatric

Approved ages
Immediate-release: type 2 diabetes, 10 to 16 years studied; not established under 10 years (label 8.4).
Usual dose
Immediate-release, 10 years and older: start 500 mg twice daily with meals; increase by 500 mg weekly (label 2.2).
Maximum dose
2,000 mg/day in two divided doses (immediate-release, label).
Neonates
Neonates: specialist input.

Kidney dosing in children: see Dosing: Altered kidney function.

renalcarematters.com, reviewed
Pediatric use (US label) US FDA label

8.4 Pediatric Use Metformin Hydrochloride Tablets The safety and effectiveness of Metformin Hydrochloride Tablets for the treatment of type 2 diabetes mellitus have been established in pediatric patients 10 to 16 years old. Safety and effectiveness of Metformin Hydrochloride have not been established in pediatric patients less than 10 years old.

Use of Metformin Hydrochloride Tablets in pediatric patients 10 to 16 years old for the treatment of type 2 diabetes mellitus is supported by evidence from adequate and well-controlled studies of Metformin Hydrochloride Tablets in adults with additional data from a controlled clinical study in pediatric patients 10 to 16 years old with type 2 diabetes mellitus, which demonstrated a similar response in glycemic control to that seen in adults [see Clinical Studies (14.1)]. In this study, adverse reactions were similar to those described in adults.

A maximum daily dose of 2000 mg of Metformin Hydrochloride Tablets are recommended. [See Dosage and Administration (2.2).]

Dosing: Older adult

Geriatric use (US label) US FDA label

8.5 Geriatric Use Controlled clinical studies of Metformin Hydrochloride Tablets did not include sufficient numbers of elderly patients to determine whether they respond differently from younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy and the higher risk of lactic acidosis. Assess renal function more frequently in elderly patients [see Warnings and Precautions (5.1)].

Dosage forms

Philippines

  • Film-coated tablet: 1 g, 500 mg, 850 mg
  • Extended-release tablet: 1 g, 500 mg, 750 mg
  • Tablet: 1 g, 500 mg, 850 mg
  • Prolonged-release tablet: 1 g, 500 mg
  • Sustained-release tablet: 1 g, 500 mg

Registered products in the Philippines

243 products registered with the Food and Drug Administration (FDA) Philippines list Metformin as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Also registered under: Metfomin Hydrochloride (1 product) · Metformin Hydrchloride (1 product) · Metformin Hyrdochloride (1 product). Products registered under these spellings are included in the table and marked.

Verify on PH FDA portal

All registered products243
Philippine FDA-registered products for Metformin
Package insert
Aartmin 850Metformin Hydrochloride
850 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Pinnacle Life Science Private Limited (Subsidiary of Aarti Drugs Limited)India
Khriz Pharma Trading Inc.
DR-XY49145
Jul 31, 2029
Aartmin 850Metformin Hydrochloride
850 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Pinnacle Life Science Private Limited (Subsidiary of Aarti Drugs Limited)India
Khriz Pharma Trading Inc.
DRP-18047
Jul 31, 2029
AceforminMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
A.C.E.P. Medical Supplies Trading
DRP-12561-08
Sep 2, 2027
AzforMetformin Hydrochloride
500 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
—
DRP-17804
Mar 12, 2031
BerametMetformin Hydrochloride
500 mg TabletClear PVC-Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Beracah Pharma Phils., Inc.Trader: Gamot Philippines, Inc.
DRP-5030
Oct 12, 2030
Bigsens XR 750Metformin hydrochloride
750 mg Extended-Release TabletAlu/PVC Blister Pack x 10's Box of 100's
RxVAT-exempt
Cadila Healthcare LimitedIndia
Zydus Healthcare Philippines, Inc.
DRP-11280
Sep 24, 2029
Bliformin-500Metformin hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Sunrise International Labs LimitedIndia
Bliss Pharma Distribution and Consultancy Corp.
DRP-16837
Jul 16, 2030
Chemophase-500Metformin hydrochloride
500 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Merit Organics Ltd.India
Khriz Pharma Trading Inc.
DRP-15688
Aug 27, 2029
DiabaseMetformin Hydrochloride
500 mg TabletClear PVC-Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Basic Pharmaceutical CorporationTrader: Gamot Philippines, Inc.
DRP-5030-02
Jul 14, 2031
Diabemin XRMetformin hydrochloride
1 g Extended-Release TabletAlu/PVC/PVDC blister pack x 10 tablets (box of 60 tablets)
RxVAT-exempt
PT. Ferron Par PharmaceuticalsIndonesia
Glorious Dexa Mandaya, Inc.Trader: PT. Dexa Medica
DRP-11806
May 2, 2027
Diabemin XRMetformin Hydrochloride
500 mg Extended-Release TabletAluminum/PVC/PVDC Blister Pack x 14's (Box of 28's)
RxVAT-exempt
PT FERRON PAR PHARMACEUTICALSIndonesia
Glorious Dexa Mandaya, Inc.Trader: PT DEXA MEDICA
DRP-5511
Oct 8, 2028
Diabemin XRMetformin hydrochloride
750 mg Extended-Release TabletAluminum/PVC/PVDC Blister Pack x 15's (Box of 30's and 60's)
RxVAT-exempt
PT Ferron Par PharmaceuticalsIndonesia
Glorious Dexa Mandaya, Inc.
DRP-14124
Jun 23, 2028
DiafatMetformin hydrochloride
1 g Film-Coated tabletAlu/clear PVC blister pack x 15 tablets (Box of 60's)
RxVAT-exempt
Lek S.A.Poland
Importer: Sandoz Philippines Corporation
DRP-7389
Oct 4, 2027
DiafatMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10 Tablets (Box of 60 Tablets)
RxVAT-exempt
Lek S.A.Poland
Importer: Sandoz Philippines Corporation
DRP-7388
Oct 4, 2027
DiametMetformin Hydrochloride
500 mg Film-Coated TabletAlu / PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mercury Laboratories Ltd.India
TGP Pharma Inc.Importer: Philgen Pharmaceuticals Inc.
DRP-14091-02
Jun 20, 2028
Diamet 500Metformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Centurion laboratories Pvt. Ltd.India
TGP Pharma Inc.Importer: Philgen Pharmaceuticals Inc.
DRP-4077-01
Jun 24, 2027
Diavin 500 XRMetformin Hydrochloride
500 mg Extended-Release TabletAlu/Clear PVC Film Coated Tablet (Box of 30's)
RxVAT-exempt
Bafna Pharmaceuticals LimitedIndia
Medethix, Inc.
DRP-16523
Apr 15, 2027
Dimet-850Metformin Hydrochloride
850 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 50's)
RxVAT-exempt
Oman Pharmaceuticals Products Co., LLCSultanate
Madecs Pharma CorporationImporter: Atlantic Pharmaceuticals, Inc.
DR-XY40156
Oct 11, 2036
DMphage ER 500Metformin Hydrochloride
500 mg Extended-Released TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Bafna Pharmaceutricals LimitedIndia
Amethyst Global (Philippines) Inc.Importer: Medethix, Inc.
DRP-15011-02
Mar 13, 2031
Emnorm ER 500Metformin Hydrochloride
500mg Extended-Release TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
IPCA Laboratories LimitedIndia
Blue Global (FZE)
DRP-5659
May 21, 2027
Etromin 1000Metformin Hydrochloride
1 g Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Trader: St. Raphael Archangel Pharmaceutical Product Distribution
DRP-14245
Aug 2, 2030
Etromin 500Metformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Trader: St. Raphael Archangel Pharmaceutical Product Distribution
DRP-14247
Aug 2, 2030
Etromin 850Metformin hydrochloride
850 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Trader: St. Raphael Archangel Pharmaceutical Product Distribution
DRP-14246
Aug 2, 2030
EuforminMetformin Hydrochloride
1 g Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 60's)
RxVAT-exempt
The ACME Laboratories LimitedBangladesh
Euro Generics International Phils., Inc.
DRP-6873
Mar 25, 2029
EuforminMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
The ACME Laboratories LimitedBangladesh
Euro Generics International Phils., Inc.
DR-XY43317
Mar 25, 2029
ForedMetformin Hydrochloride
500 mg Film Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
777 Red Pharma Inc.Importer: Philgen Pharmaceuticals Inc.
DRP-4077-05
Jun 24, 2027
ForedMetformin Hydrochloride
500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mercury Laboratories Ltd.India
777 Red Pharma Inc.Importer: Philgen Pharmaceuticals, Inc.
DRP-14091-01
Jun 20, 2028
ForherdinMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Medchoice Women’s Health (MCWH), Inc.
DRP-7406-06
Jan 12, 2027
FormetMetformin Hydrochloride
500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mercury Laboratories Ltd.India
Philgen Pharmaceuticals Inc.
DRP-14091
Jun 20, 2028
Formet 500Metformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 90's) [for DOH Supply]
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Philgen Pharmaceuticals Inc.
DRP-4077
Jun 24, 2027
FormetinMetformin Hydrochloride
500 mg Film-Coated TabletBlister Pack x 10's (Box of 60's)
RxVAT-exempt
Intas Pharmaceuticals LimitedIndia
Phil. Pharmawealth, Inc.Importer: Singapore Genebio, Inc.
DR-XY39832
Jul 27, 2031
FormexMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Eadriex Pharmaceuticals, Phils., Inc.
DRP-8065
May 6, 2029
FormigenMetformin hydrochloride
1 g Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
Eba Generisch Trading Inc.
DRP-12562-05
Sep 2, 2027
FormigenMetformin hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
EBA Generisch Trading Inc.
DRP-12561-05
Sep 2, 2027
Formigen 1000Metformin hydrochloride
1 g Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Trader: Eba Generisch Trading Inc.
DRP-14254
Aug 4, 2030
Formigen 500Metformin hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Trader: Eba Generisch Trading Inc.
DRP-14256
Aug 4, 2030
Formigen 850Metformin hydrochloride
850 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Trader: Eba Generisch Trading Inc.
DRP-14255
Aug 4, 2030
ForniddMetformin Hydrochloride
500 mg Film-Coated TabletAlu Foil Strip x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Trader: sanofi-aventis Philippines Inc.
DRP-3033
Feb 4, 2030
Fornidd XRMetformin HyrdochlorideVariant spelling
1 g Extended-Release TabletAlu Clear PVC/PVDC Blister Pack x 10's (Box of 100's); Alu Clear PVC/PVDC Blister Pack x 20's (Box of 100's)
Rx
Inventia Healthcare LimitedIndia
Sanofi-Aventis Philippines, Inc.Importer: I.E. Medica, Inc.
DRP-3520
Jan 30, 2027
Fornidd XRMetformin Hydrochloride
500 mg Extended-Release TabletAlu/PVC/PVDC Blister Pack x 20's Box of 100's; Alu/Clear PVC/PVDC Blister Pack Box of 2's as physician's sample
RxVAT-exempt
Inventia Healthcare Ltd.India
Sanofi-Aventis, Philippines , Inc.Importer: I.E. Medica, Inc.
DRP-2501-01
Sep 29, 2029
GluceeminMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
CDMed Pharmaceutical and Medical SupplyImporter: Pharmakon Biotec Inc.
DRP-13845-05
Apr 28, 2028
GlucoformMetformin Hydrochloride
500 mg TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Ashford Pharmaceutical Laboratories, Inc.Philippines
Trader: Vendiz Pharmaceuticals, Inc.
DRP-2055
Aug 5, 2028
GlucominMetformin hydrochloride
500 mg Film-Coated TabletAlu-Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Randril International Co., Inc.
DRP-12693
Aug 7, 2031
GlucophageMetformin Hydrochloride
1 g TabletClear PVC/Aluminum Blister Strip x 15's (Box of 60's)
RxVAT-exempt
Merck SanteFrance
Merck, Inc.
DRP-6511
Jun 7, 2027
Glucophage ForteMetformin Hydrochloride
850 mg Film-coated tablet
RxVAT-exempt
—
Importer: Merck, Inc.
DRP-6510
Feb 1, 2027
Glucophage XRMetformin hydrochloride
1 g Extended-Release TabletClear PVC/PVDC Alu Blister Pack x 10's (Box of 60's)
RxVAT-exempt
Merck SanteFrance
Merck, Inc.
DRP-6509
Sep 3, 2030
Glucophage XRMetformin Hydrochloride
500 mg Extended-Release Tablet
RxVAT-exempt
PT. Merck TbkIndonesia
Merck, Inc.
DRP-15546
Feb 10, 2031
Glucophage XRMetformin hydrochloride
500 mg Extended-Release TabletClear PVC/PVDC Alu Blister Pack x 15's (Box of 30's)
RxVAT-exempt
Merck SanteFrance
Merck, Inc.
DRP-6507
Sep 3, 2030
Glucophage XRMetformin Hydrochloride
750 mg Extended-Release TabletAlu/PVC/PVDC Blister Pack x 15's (Box of 60's)
RxVAT-exempt
PT. Merck TbkIndonesia
Merck, Inc.
DRP-16842
Jan 15, 2031
Glucophage XRMetformin hydrochloride
750 mg Extended-Release TabletAlu/PVC/PVDC Blister Pack x 15's (Box of 60's)
RxVAT-exempt
Merck SanteFrance
Merck, Inc.
DRP-6508
Sep 3, 2030
Glucosaph-GE850Metformin hydrochloride
850 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Genom Biotech Pvt. Ltd.India
Nelpa Lifesciences, Inc.
DRP-17523
Jan 19, 2031
GlucosilMetformin Hydrochloride
500mg TabletAlu-Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Drugmakers Laboratories, Inc.Philippines
—
DRP-9135
Oct 20, 2027
GlucosilMetformin Hydrochloride
850 mg TabletAlu/Clear PVC Blister pack x 10's (Box of 100's)
RxVAT-exempt
Drugmaker's Laboratories Inc.Philippines
—
DRP-8276
Jul 30, 2031
GlucostopMetformin Hydrochloride
500 mg TabletClear PVC-Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Medirich Pharma Distribution Corp.Trader: Gamot Philippines, Inc.
DRP-5030-01
Jul 30, 2031
GlucotinMetformin hydrochloride
1 g Film-Coated TabletAlu-Clear PVC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
TGP Pharma inc.Trader: Gamot Philippines, Inc.
DR-XY38914
Jan 4, 2031
GlucotinMetformin Hydrochloride
850 mg Film-Coated TabletAluminum/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
TGP Pharma Inc.Trader: Gamot Philippines, Inc.
DR-XY39669
Jun 22, 2031
GludinMetformin Hydrochloride
500 mg Film-coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
MedChoice Endocrine Group, Inc.
DRP-7406-03
Jan 12, 2027
GludinMetformin Hydrochloride
500 mg Film-Coated TabletAlu-PVC Blister pack x 10's (Box of 100's)
RxVAT-exempt
Sydenham Laboratories, Inc.Philippines
Trader: Medchoice Endocrine Group, Inc.
DRP-7736
Aug 17, 2030
GludinMetformin Hydrochloride
850 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Sydenham Laboratories, Inc.Philippines
Trader: Medchoice Endocrine Group, Inc.
DRP-7737
Mar 16, 2031
Gludin XRMetformin hydrochloride
1 g Extended Release TabletAlu/PVC/PVDC Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Globela Pharma Private LimitedIndia
Medchoice Endocrine Group, Inc.Importer: AMB HK Enterprises Inc.
DRP-10477-02
Sep 30, 2031
Gluko-SMetformin hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Starpharm, Inc.
DRP-12561-06
Sep 2, 2027
GlumetMetformin Hydrochloride
1 g Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10 Blister packs x 10 Tablets)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DRP-12900
Nov 16, 2027
GlumetMetformin hydrochloride
1 g Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Harman Finochem LimitedIndia
Unilab, Inc.
DRP-16505
Apr 2, 2030
GlumetMetformin Hydrochloride
1 g Film-Coated TabletAlu/Clear PVC Blister Pack of 15's (Box of 60'S)
RxVAT-exempt
Lek S.A.Poland
Unilab, Inc.Importer: Sandoz Philippines Corporation
DRP-7389-02
Oct 4, 2027
GlumetMetformin Hydrochloride
1 g TabletAlu/Alu Foil Strip x 4's (Box of 100's)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DRP-10044
Sep 5, 2037
GlumetMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 60's)
RxVAT-exempt
Lek S.A.Poland
UNILAB, Inc.Importer: Sandoz Philippines Corporation
DRP-7388-02
Oct 4, 2027
GlumetMetformin hydrochloride
500 mg TabletStrip Foil x 4s (Box of 100's)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, INC.
DRP-10043
May 31, 2030
GlumetMetformin hydrochloride
500 mg TabletAlu/Alu Blister Strip Foil x 10’s (Box of 100’s)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DRP-18090
May 4, 2031
GlumetMetformin hydrochloride
850 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Harman Finochem LimitedIndia
Unilab, Inc.
DRP-17514
Jan 15, 2031
GlumetMetformin Hydrochloride
850 mg TabletFlex Foil x 4's (Box of 100's)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
UNILAB , Inc.Trader: Ritemed Phils., Inc.
DRP-9981-01
May 13, 2031
Glumet-XRMetformin Hydrochloride
1 g Prolonged-Release TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
UNILAB, Inc.
DRP-13868
May 5, 2028
Glumet-XRMetformin hydrochloride
500 mg Extended-Release TabletStrip Foil x 4's Box of 100's
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DRP-10042
Feb 16, 2029
GlumiraMetformin Hydrochloride
500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Shouguang Fukang Pharmaceutical Co., Ltd.China
Hexagon Pharmaceuticals
DRP-17497
Jan 12, 2031
Gluventa PR 1000Metformin hydrochloride
1 g Prolonged-Release TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Healol Pharma Corporation
DRP-15097
Apr 29, 2029
Gluventa PR 500Metformin hydrochloride
500 mg Prolonged-Release TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Healol Pharma Corporation
DRP-15098
Apr 29, 2029
Gluventa PR 750Metformin hydrochloride
750 mg Extended-Release TabletAlu/PVC-PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Healol Pharma Corporation
DRP-12015
May 30, 2027
GLYCELIFEMetformin hydrochloride
500 mg Film-Coated TabletAlu/PVC-PVDC Blister Pack x 10's (Box of 100’s)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
Life and Health Source Pharmaceutical Distribution Co.Importer: AMB HK Enterprises Inc.
DRP-11939-04
May 20, 2027
Glycemed 1000Metformin Hydrochloride
1 g Extended-Release TabletAlu/PVC/PVDC Blister pack x 14's (Box of 28's)
RxVAT-exempt
Ind-Swift LimitedIndia
Medinova Pharmaceutical Inc.
DRP-15466
Jul 11, 2029
Glycemed 500Metformin Hydrochloride
500 mg Extended-Release TabletAlu/ PVC/PVDC Blister pack x 14's (Box of 28's)
RxVAT-exempt
Ind-Swift LimitedIndia
Medinova Pharmaceutical Inc.
DRP-15468
Jul 11, 2029
Glycemed 750Metformin Hydrochloride
750 mg Extended-Release TabletAlu-PVC Blister Pack by 14's
RxVAT-exempt
Ind-Swift LimitedIndia
Medinova Pharmaceutical Inc.
DRP-15467
Jul 11, 2029
GlycemetMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10’s (Box of 30’s and 100’s)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Cp., Ltd.China
AMB HK Enterprises Inc.
DRP-14853
May 26, 2031
GlycemetMetformin hydrochloride
500mg Film-Coated TabletAlu/PVC-PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc.
DRP-11939
May 20, 2027
GlyceminMetformin Hydrochloride
500 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Wallace Pharmaceuticals Pvt. Ltd.India
Hexagon Pharmaceuticals
DRP-15793
Sep 18, 2029
Glycemin SRMetformin Hydrochloride
500 mg Sustained-Release TabletAlu/PVC Blister Pack (Box of 100's)
RxVAT-exempt
Wallace Pharmaceuticals Pvt. Ltd.India
Hexagon Pharmaceuticals
DRP-16326
Feb 7, 2030
GlyformetMetformin hydrochloride
1 g Extended Release TabletAlu/PVC/PVDC Blister Pack x 10’s (Box of 30’s and 100’s)
RxVAT-exempt
Globela Pharma Private LimitedIndia
Corbridge Group Phils., Inc.Importer: AMB HK Enterprises Inc.
DRP-10477-01
Sep 30, 2036
GlyformetMetformin Hydrochloride
1g Extended-Release TabletAlu Clear PVC/PVDC Blister Pack x 10's; (Box of 100's); Alu Clear PVC/PVDC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Inventia Healthcare Pvt. Ltd.India
Corbridge Group Phils., Inc.Importer: I.E. Medica, Inc.
DRP-3520-02
Jan 30, 2027
GlyformetMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's Box of 100's
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Corbridge Group Phils., Inc.
DR-XY41497
Dec 18, 2027
GlyformetMetformin Hydrochloride
850 mg Film-Coated TabletAlu-Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Corbridge Group Phils., Inc.
DR-XY40977
Jun 21, 2027
Glyminov 500Metformin (as hydrochloride)
500 mg Film- Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Ratnaris Pharmaceuticals Private LimitedIndia
Medinova Pharmaceutical Inc.
DRP-18762
Sep 1, 2031
GlymoraMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10’s (Box of 30’s and 100’s)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-14853-05
May 26, 2031
GlyvexamedMetformin (as hydrochloride)
500 mg Film- Coated TabletAlu/ Clear PVC Blister Pack x 10's (Box of 30's. Box of 100's)
RxVAT-exempt
Ratnaris Pharmaceuticals Private LimitedIndia
Medinova Pharmaceutical Inc.
DRP-18761
Sep 1, 2031
GMet 1000Metformin Hydrochloride
1 g Prolonged Release TabletAlu-clear PVC/PVDC Blister Pack x 10's (Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Orange Biotec Inc.
DRP-13485
Feb 27, 2028
GMet 500Metformin Hydrochloride
500 mg Prolonged release tabletAlu-PVC/PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Inventia Healthcare Limited.India
Orange Biotec Inc.
DRP-13694
Apr 13, 2028
GoforminMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Applied Pharmaceutical Distribution Inc.Importer: AMB HK Enterprises Inc.
DRP-14853-01
May 8, 2031
HexametMetformin hydrochloride
500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Shouguang Fukang Pharmaceutical Co., Ltd.China
Hexagon PharmaceuticalsTrader: Nanjing Pharmacare Co., Ltd.
DRP-13929
May 18, 2028
Hexamin SRMetformin Hydrochloride
500 mg Sustained-Release TabletAlu/Amber PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Wallace Pharmaceuticals Pvt. Ltd.India
Hexagon Pharmaceuticals
DRP-16841
Jul 16, 2030
HovidEuformMetformin Hydrochloride
500 mg Film-Coated TabletAlu/PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Hovid BerhadMalaysia
Hovid Inc.
DRP-6999
Mar 7, 2031
HovidEuform XRMetformin hydrochloride
500 mg Extended-Release TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hovid BerhadMalaysia
Hovid Inc.
DR-XY45052
Feb 10, 2031
HumametMetformin Hydrochloride
500 mg Film-Coated TabletAlu/PVC Blister Pack x 10’s (Box of 60’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Trader: A. Menarini Philippines, Inc.
DR-XY24394
May 15, 2031
HumametMetformin Hydrochloride
850 mg TabletPVC/PE/PVDC Blister Pack x 10's (Box of 60's)
RxVAT-exempt
HIZON LABORATORIES, INC.Philippines
Trader: A.MENARINI PHILIPPINES, INC.
DR-XY28729
Jun 27, 2028
Humamet®Metformin Hydrochloride
500 mg Film-Coated TabletBlister Pack x 10's (Box of 30's, 60's and 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
A. Menarini Philippines, Inc.Trader: Gold Life Distribution Phils. Inc.
DRP-10086-02
Feb 22, 2027
HUMAMET®Metformin Hydrochloride
850 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 60's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
A. Menarini Philippines, Inc.Trader: Dr. Zen's Research Inc.
DRP-16851-01
Dec 18, 2027
I-MaxMetformin Hydrochloride
500 mg Film-Coated tabletBlister pack x 10's (Box of 60's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Patriot Pharmaceuticals Corporation
DR-XY38629
Oct 13, 2030
LifemetMetformin Hydrochloride
500 mg Film-Coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Bulacan
Trader: Gold Life Distribution Phils. Inc.
DRP-10086
Feb 22, 2032
MaximetMetformin hydrochloride
500 mg Film-Coated TabletAlu/PVC-PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
Trumed PharmaceuticalsImporter: AMB HK Enterprises Inc.
DRP-11939-03
May 20, 2027
MaximetMetformin Hydrochloride
500 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Wallace Pharmaceuticals Pvt. Ltd.India
Trumed PharmaceuticalsImporter: Hexagon Pharmaceuticals
DRP-15793-01
Sep 18, 2029
MeclorminMetformin hydrochloride
500mg Film-Coated TabletPVC/Alu blister pack x 10's (Box of 100's)
RxVAT-exempt
Swiss Parenterals, Inc.India
International Apex Pharmaceuticals, Inc.
DR-XY47498
Nov 17, 2026Past listed date
Medformin-500Metformin hydrochloride
500mg Film Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Acme Formulation Pvt. Ltd.India
Medinova Pharmaceutical Inc.
DRP-13465
Feb 23, 2028
MedgluMetformin hydrochloride
500 mg Film-Coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Medhaus Pharma, Incorporated
DR-XY39377
May 9, 2031
MeforinMetformin Hydrochloride
500mg TabletAlu/PVC Blister Pack x 10's (Box of 10 Blister packs x 10 Tablets)
RxVAT-exempt
Celogen Generics Private Ltd.India
Endure Medical, Inc.
DR-XY48451
Nov 7, 2027
MelforMetformin Hydrochloride
1 g Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
Amiel Trading Inc.
DRP-12562-06
Sep 2, 2027
Melmet SR 1000Metformin Hydrochloride
1 g Sustained Release TabletAlu/PVC Blister Pack x 10's (Box of 30's); Alu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Philippines Inc.
DR-XY43079
Mar 17, 2029
Melmet SR 500Metformin Hydrochloride
500 mg Sustained Release tabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Philippines Inc.
DRP-5797
Jul 31, 2029
Melmet-850Metformin (as hydrochloride)
850 mg Film Coated TabletBlister Pack x 10's (Box of 50's and 100's)
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Philippines Inc.
DRP-1869
Jul 9, 2031
Met-A-DayMetformin Hydrochloride
1 g Extended-Release TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Innogen Pharmaceuticals, Inc.
DRP-10136
Oct 18, 2028
MetagoldMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Brilliantmeed, Inc.
DRP-12561-12
Sep 2, 2027
MetcoreMetformin Hydrochloride
500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Acme Formulation Pvt Ltd.India
Triple Tact Import & Export Corp.
DRP-12807
Oct 7, 2027
MetfnMetformin hydrochloride
1 g Film-Coated TabletAlu/PVC/PVDC blister pack x 10's (Box of 30's)
RxVAT-exempt
Globela Pharma Private LimitedIndia
AMB HK ENTERPRISES INC.
DRP-10479
Sep 30, 2031
MetfnMetformin Hydrochloride
500mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 3 blister packs x 10 tablets)
RxVAT-exempt
Globela Pharma Private LimitedIndia
Amb Hk Enterprises Inc.Importer: AMB HK Enterprises Inc.
DRP-13560
Mar 9, 2028
MetfnMetformin Hydrochloride
850 mg Film-coated TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Globela Pharma Private LimitedIndia
AMB HK Enterprises Inc.
DRP-13806
Apr 27, 2028
Metfor PR 1000.Metformin hydrochloride
1 g Prolonged Release TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 3 blister packs x 10 tablets)
RxVAT-exempt
USV Private LimitedIndia
The Cathay YSS Distributors Co., Inc.
DR-XY48463
Nov 14, 2027
Metfor XRMetformin Hydrochloride
500 mg Extended-Release TabletAlu/PVC/PVDC Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Globela Pharma Private LimitedIndia
The Cathay Yss Distributors Co., Inc.Importer: AMB HK Enterprises Inc.
DRP-10478-01
Sep 30, 2031
Metfor XRMetformin hydrochloride
750 mg Extended Release TabletStrip Foil x 6's (Box of 30's)
RxVAT-exempt
El Laboratories, IncPhilippines
Trader: The Cathay YSS Distributors Co., Inc.
DR-XY44791
Feb 9, 2031
Metfor XRMetformin hydrochloride
750 mg Extended-Release TabletAluminum/PVC/PVDC Blister Pack x 15’s (Box of 30’s)
RxVAT-exempt
PT Ferron Par PharmaceuticalsIndonesia
The Cathay YSS Distributors Co., Inc.Importer: Glorious Dexa Mandaya, Inc.Trader: PT Dexa Medica
DRP-14124-01
Jun 23, 2028
MetforedMetformin Hydrochloride
500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Sapphire Lifesciences Pvt. LtdIndia
777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc.
DRP-6686-01
May 4, 2031
METFOREDMetformin Hydrochloride
500 mg Film-Coated TabletAlu/PVC Blister Pack x 10’s (Box of 30’s); Alu/PVC Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Genom Biotech Pvt. Ltd.India
777 RED PHARMA INC.Importer: Nelpa Lifesciences, Inc.
DRP-6686-03
Mar 23, 2032
MetformixMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hiral Labs LimitedIndia
Aglobal Care, Inc.
DRP-13470
Feb 28, 2028
MetforzeMetformin Hydrochloride
500 mg Film-Coated TabletAlu/PVC-PVDC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Globela Pharma Private LimitedIndia
AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc.
DRP-13723
Mar 31, 2028
MetokonMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Pharmakon Biotec Inc.
DRP-13845
Apr 28, 2028
MetoxedMetformin Hydrochloride
500 mg Film-coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Exemed PharmaceuticalsIndia
AMB HK Enterprises Inc
DRP-17358
Nov 20, 2030
Metpen-850Metformin Hydrochloride
850 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Pinnacle Life Science Private Limited (Subsidiary of Aarti Drugs Limited)India
A. Pendragon International Distribution OpcImporter: Khriz Pharma Trading Inc.
DRP-18047-01
Jul 31, 2029
Metpro-1000Metformin Hydrochloride
1 g Prolonged-Release TabletAlu-clear PVC/PVDC Blister Pack x 10's (Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Preventia Healthcare Inc.Importer: Orange Biotec Inc.
DRP-13485-01
Feb 27, 2028
MetrolMetformin Hydrochloride
850 mg Film-Coated TabletAlu/Clear PVDC/PVC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Meedpharma Medical Supplies & Equipment DistributorTrader: Vamsler Phils. Incorporated
DR-XY44868
Oct 15, 2031
MetrometMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Metro Pharma Philippines Inc.
DRP-7406-05
Jan 12, 2027
MetstanMetformin Hydrochloride
500 mg Film-Coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Westfield Pharmaceuticals, Inc.Trader: Gold Life Distribution Phils. Inc.
DRP-10086-1
Feb 22, 2027
MetsureMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100’s)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Rule Med Pharma CorpImporter: Pharmakon Biotec Inc.
DRP-13845-02
Apr 28, 2028
Metta SRMetformin hydrochloride
500 mg Extended-Release TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Torrent Pharmaceuticals Ltd.India
Torrent Pharma Philippines, Inc.
DRP-2445
Sep 6, 2030
MetterMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Errapel Pharmed Corp.
DRP-12561-09
Sep 2, 2027
Metxr 1000Metformin hydrochloride
1 g Extended Release TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Globela Pharma Private LimitedIndia
AMB HK Enterprises Inc.
DRP-10477
Sep 30, 2036
Metxr 500Metformin hydrochloride
500 mg Extended Release TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Globela Pharma Private LimitedIndia
AMB HK Enterprises Inc.
DRP-10478
Sep 30, 2031
Metzan 850Metformin Hydrochloride
850 mg Film-Coated TabletAlu / Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Triple 888 Medical and Pharma Inc.
DRP-14246-01
Aug 2, 2030
Metzan-500Metformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Triple 888 Medical and Pharma Inc.
DRP-12561-10
Sep 2, 2027
MetzenMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10’s (Box of 30’s and 100’s)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-14853-04
May 25, 2031
MymetMetformin Hydrochloride
500mg Film-Coated TabletClear PVC/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
New Myrex Laboratories, Inc.Bulacan
—
DRP-7448
Nov 2, 2032
NanometMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Nanomed Pharma Inc.Importer: Pharmakon Biotec Inc.
DRP-13845-04
Apr 28, 2028
Neoform 500Metformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
GX International, Inc.
DRP-7406-04
Jan 12, 2027
Neoform® 500Metformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
GX International, Inc.Trader: Eadriex Pharmaceuticals, Phils., Inc.
DRP-8065-03
May 6, 2029
NeometMetformin hydrochloride
500 mg Film-Coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Littman Drug Corporation
DR-XY39744
Jul 22, 2031
Nevox XRMetformin Hydrochloride
500 mg Extended-Release TabletAluminum Foil Strip x 10's (Box of 30's)
RxVAT-exempt
PT. Kalbe Farma TbkIndonesia
Globo Asiatico Enterprises, Inc.
DR-XY45817
Mar 15, 2027
NidcorMetformin hydrochloride
500 mg Film-coated TabletFoil Strip x 10’s (Box of 100’s)
RxVAT-exempt
Lloyd Laboratories, Inc.Bulacan
Trader: PNSV Asia Corporation
DR-XY30095
May 2, 2031
NifrominMetformin hydrochloride
1 g Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-12562-04
Sep 2, 2027
NifrominMetfomin HydrochlorideVariant spelling
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
Rx
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-12561-03
Sep 2, 2027
NifrominMetformin Hydrochloride
850 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product DistributionTrader: Eba Generisch Trading Inc.
DRP-14255-04
Sep 19, 2031
NimrofMetformin hydrochloride
1 g Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St.Raphael Archangel Pharmaceutical Product Distribution
DRP-12562-01
Sep 2, 2027
NimrofMetformin hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-12561-01
Sep 2, 2027
NimrofMetformin Hydrochloride
850 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product DistributionTrader: Eba Generisch Trading Inc.
DRP-14255-01
Sep 22, 2031
NoneMetformin Hydrochloride
1 g Extended-Release TabletAlu Clear PVC/PVDC Blister Pack x 10's (Box of 100's); Alu Clear PVC/PVDC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Inventia Healthcare Pvt. Ltd.India
Vivilon Pharmaceuticals Inc.Importer: I.E. Medica, Inc.
DRP 3520-04
Jan 30, 2027
NoneMetformin Hydrochloride
1 g Extended-Release TabletClear PVC/PVDC Alu Blister Pack x 10's Box of 60's
RxVAT-exempt
Merck SanteFrance
Philusa CorporationImporter: Merck, Inc.
DRP-6509-01
Mar 20, 2027
NoneMetformin Hydrochloride
1 g Sustained-Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Vitalink Health Products, Inc.
DR-XY42929
Nov 12, 2028
NoneMetformin Hydrochloride
500 mg Extended-Release TabletAlu/Alu Blister Pack x 10’s Box of 30’s
RxVAT-exempt
Ipca Laboratories Ltd.India
International Pharmaceuticals, Inc.Importer: Blue Global (FZE)
DRP-5659-02
May 21, 2027
NoneMetformin Hydrochloride
500 mg Extended-Released TabletAlu / Clear PVC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Bafna Pharmaceutricals LimitedIndia
Patriot Pharmaceuticals CorporationImporter: Medethix, Inc.
DRP-15011-01
Mar 13, 2031
NoneMetformin Hydrochloride
500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 90's & 100's)
RxVAT-exempt
Celogen Pharma Pvt. Ltd.India
Endure Medical, Inc.
DR-XY46324
May 2, 2028
NoneMetformin (as hydrochloride)
500 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 50's); Alu/Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Metz Pharmaceuticals, Inc.
DR-XY46558
Apr 30, 2029
NoneMetformin Hydrochloride
500 mg Film-Coated TabletAlu-Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
St. Joseph DrugstoreTrader: Randril Internation Co., Inc.
DRP-12693-01
Jun 2, 2031
NoneMetformin hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Acme Formulation Pvt. Ltd.India
MED4UImporter: Medinova Pharmaceutical Inc.
DRP-13465-01
Feb 23, 2028
NoneMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100’s)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Reta DrugImporter: Pharmakon Biotec Inc.
DRP-13845-06
Apr 28, 2028
NoneMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100’s)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Cyden Medicale Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-13845-08
Apr 28, 2028
NoneMetformin Hydrochloride
500 mg Film-Coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
PT. Merck TBKIndonesia
Philusa CorporationImporter: Merck, Inc.
DRP-6512-01
Jan 19, 2028
NoneMetformin Hydrochloride
500 mg Film-Coated TabletClear PVC/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
New Myrex Laboratories, Inc.Philippines
Farmacia Ni Dok, Inc.
DRP-7448-01
Nov 2, 2027
NoneMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Actimed, Inc.Trader: Eadriex Pharmaceuticals, Phils., Inc.
DRP-8065-02
May 6, 2029
NoneMetformin Hydrochloride
500 mg Film-Coated TabletFoil Strip x 10's (Box of 100's)
RxVAT-exempt
Pascual Laboratories, Inc.Philippines
Pharex Health Corporation
DRP-8408
Jul 13, 2028
NoneMetformin Hydrochloride
500 mg Film-Coated TabletFoil Strip x 10's (Box of 100's)
RxVAT-exempt
Pascual Laboratories, Inc.Philippines
Rose Pharmacy, Incorporated
DRP-8408-01
Jul 13, 2028
NoneMetformin Hydrochloride
500 mg Film-Coated TabletFoil Strip x 10's (Box of 100's)
RxVAT-exempt
Pascual Laboratories, Inc.Philippines
South Star Drug
DRP-8408-02
Jul 13, 2028
NoneMetformin hydrochloride
500 mg Film-Coated TabletsAlu/PVC-PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
Trumed PharmaceuticalsImporter: AMB HK Enterprises, Inc.
DRP-11930-02
May 20, 2027
NoneMetformin hydrochloride
500 mg Sustained-Release TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
USV Private LimitedIndia
RITEMED PHILS., INC.
DR-XY43094
Dec 18, 2028
NoneMetformin hydrochloride
500 mg Sustained-Release TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
USV Private LimitedIndia
Ritemed Phils., Inc.
DRP-14732
Dec 18, 2028
NoneMetformin hydrochloride
500 mg TabletFoil Strip x 4's (Box of 100's)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: Ritemed Phils., Inc.
DR-XY27415
Mar 6, 2031
NoneMetformin Hydrochloride
500 mg TabletAlu/PVC Blister pack x 10’s (Box of 100’s)
RxVAT-exempt
Wallace Pharmaceuticals Pvt. Ltd.India
Qualifirst Health Inc.Importer: Hexagon Pharmaceuticals
DRP-15793-02
Sep 18, 2029
NoneMetformin Hydrochloride
500 mg TabletClear PVC-Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Foramen Products CorporationTrader: Gamot Philippines, Inc.
DRP-5030-03
Jul 20, 2031
NoneMetformin Hydrochloride
500 mg TabletAlu/ PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medico Remedies LimitedIndia
Medethix, Inc.Importer: I.E. Medica, Inc.
DRP-5363-01
Jun 26, 2029
NoneMetformin Hydrochloride
500 mg TabletAlu/PVC Blister pack x 10's (Box of 90's, 100's and 30's)
RxVAT-exempt
Medico Remedies LimitedIndia
Medethix, Inc.
DRP-5364
Jun 26, 2029
NoneMetformin Hydrochloride
500mg Film-Coated TabletClear PVC/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
New Myrex Laboratories, Inc.Philippines
Steinbach Products Inc.
DRP-7448-02
Nov 2, 2027
NoneMetformin Hydrochloride
750 mg Extended-Release TabletAlu/PVC/PVDC Blister Pack x 15's Box of 60's
RxVAT-exempt
Merck SanteFrance
Philusa CorporationImporter: Merck, Inc.
DRP-6508-01
Jan 14, 2029
NoneMetformin Hydrochloride
850 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 50's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Dr. Zen’s Research, Inc.
DR-XY41499
Dec 18, 2027
NoneMetformin Hydrochloride
850 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Celogen Pharma Pvt., Ltd.India
Endure Medical Inc.
DR-XY46325
May 2, 2028
NoneMetformin Hydrochloride
850 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 50's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Dr. Zen's Research, Inc.
DRP-16851
Dec 18, 2027
NoneMetformin Hydrochloride
850 mg Film-Coated TabletPVC/Aluminum Blister Pack x 8's (Box of 120's)
RxVAT-exempt
P.T. Merck TBKIndonesia
Philusa CorporationImporter: Merck, Inc.
DRP-6510-01
Feb 1, 2027
NoneMetformin Hydrochloride
850 mg Film-Coated TabletAlu/PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
—
DRP-7686
Feb 3, 2031
NoneMetformin Hydrochloride
850 mg TabletFlex Foil x 4's (Box of 100's)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: Ritemed Phils., Inc.
DRP-9981
Sep 17, 2031
NorgluminMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100’s)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Northmed Pharma and Medical Supplies DistributionImporter: Pharmakon Biotec Inc.
DRP-13845-07
Apr 28, 2028
NormaxMetformin Hydrochloride
500 mg Extended-Release TabletAlu/PVC/PVDC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Bell-Kenz Pharma Inc.Importer: I.E. Medica, Inc.
DRP-2501-03
Sep 29, 2029
Obimet 500Metformin Hydrochloride
500 mg Extended-Release TabletAlu/PVC/PVDC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
I.E. Medica, Inc.
DRP-2501
Sep 29, 2029
Panfor Pr-500Metformin HydrchlorideVariant spelling
500 mg Prolonged-Release TabletAlu-PVC/PVDC Blister Pack x 10's (Box of 100' s)
Rx
Inventia Healthcare LimitedIndia
Metro Drug, IncImporter: Mega Lifesciences Limited Inc.Trader: Mega Lifesciences Limited Inc.
DR-XY48800
Jun 30, 2028
Panfor SR-1000Metformin Hydrochloride
1 g Sustained-release tabletAlu/Clear PVC/PVDC Blister x 20's (Box of 100's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Metro Drug, Inc.Importer: Mega Lifesciences Limited Inc.Trader: Mega Lifesciences (Australia) Pty. Ltd.
DR-XY34573
Mar 27, 2029
Panfor SR-500Metformin Hydrochloride
500mg Sustained-Release TabletAlu/Clear PVC/PVDC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Metro Drug, Inc.Importer: Mega Lifesciences Limited Inc.Trader: Mega Lifesciences (Australia) Pty. Ltd.
DR-XY34377
Mar 13, 2030
Philmet-500Metformin hydrochloride
500 mg Film-Coated TabletAlu/PVC-PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-11939-01
May 20, 2027
Proglutrol 1000Metformin Hydrochloride
1 g Extended-Release TabletAlu Clear PVC/PVDC Blister Pack x 10's (Box of 100's); Alu Clear PVC/PVDC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Healol Pharma CorporationImporter: I.E. Medica, Inc.
DRP-3520-03
Jan 30, 2027
Proglutrol 500Metformin Hydrochloride
500 mg Extended-Release TabletAlu/PVC/PVDC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Inventia Healthcare Ltd.India
Healol Pharma CorporationImporter: I.E. Medica, Inc.
DRP-2501-04
Sep 29, 2029
RaforMetformin hydrochloride
1 g Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-12562-02
Sep 2, 2027
RaforMetformin hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
ST. Raphael Archangel Pharmaceutical Product Distribution
DRP-12561-02
Sep 2, 2027
RaforMetformin Hydrochloride
850 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product DistributionTrader: Eba Generisch Trading Inc.
DRP-14255-02
Sep 22, 2031
ReformMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Transcend Phils., Inc.Trader: Eadriex Pharmaceuticals, Phils., Inc.
DRP-8065-01
May 6, 2029
RegimetMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Regimed Pharmaceutical Distributor
DRP-12561-13
Sep 2, 2027
SheforminMetformin Hydrochloride
500 mg Film-Coated TabletAlu/ Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Kain’s Trading Corp.Importer: Pharmakon Biotec Inc.
DRP-13845-03
Apr 28, 2028
SplendametMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Altomed Pharmaceuticals, Inc.Trader: Vitalink Health Products, Inc.
DR-XY43159
Feb 4, 2029
SucranormMetformin Hydrochloride
850 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 4's Box of 40's
RxVAT-exempt
The ACME Laboratories LimitedBangladesh
Euro Generics International Phils., Inc.
DRP-6871
Mar 25, 2029
SucrolMetformin Hydrochloride
500 mg tabletAlu/PVC Blister Pack x 10' s Box of 100's
RxVAT-exempt
Medico Remedies LimitedIndia
I.E. Medica, Inc.
DRP-5363
Jun 26, 2029
SugadropMetformin Hydrochloride
500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Primera Pharma Corporation
DR-XY38628
Oct 13, 2031
SugargoneMetformin hydrochloride
500 mg Film-Coated TabletAlu / Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hiral Labs LimitedIndia
TGIF Pharmaceutical Trading Inc.Importer: Aglobal Care, Inc.
DRP-13470-01
Feb 28, 2028
SugartrolMetformin Hydrochloride
1g Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 Blister Packs x 10 Tablets; Box of 10 Blister Packs x 10 Tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Eba Generisch Trading Inc.
DRP-12562-07
Sep 2, 2027
SugartrolMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister pack x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Eba Generisch Trading Inc.
DRP-12561-11
Sep 2, 2027
SugartrolMetformin Hydrochloride
850 mg Film-Coated TabletAlu / Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Eba Generish Trading Inc.
DRP-14246-02
Aug 2, 2030
Sukrivent 1000Metformin Hydrochloride
1 g Prolonged Release TabletPVC/PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Phagrosea Corporation
DRP-15799
Sep 18, 2029
Sukrivent 500Metformin Hydrochloride
500 mg Prolonged Release TabletPVC/PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Phagrosea Corporation
DRP-15798
Sep 18, 2029
SwitlesMetformin hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
Curecare Pharmaceutical Products Distribution
DRP-12561-07
Sep 2, 2027
TechnometMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
One technodrug Life Sciences Inc.Importer: Pharmakon Biotec Inc.
DRP-13845-01
Apr 28, 2028
Theomet-500Metformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC blister pack x 10’s Box of 100’s
RxVAT-exempt
Theon Pharmaceuticals LimitedIndia
Suhitas Pharmaceuticals Inc.
DRP-8238
Jun 18, 2029
Theomet-500Metformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC blister pack x 10’s Box of 100’s
RxVAT-exempt
Theon Pharmaceuticals LimitedIndia
Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-8238-01
Jun 18, 2029
ThorminMetformin hydrochloride
1 g Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-12562-03
Sep 2, 2027
ThorminMetformin hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 3 blister packs x 10 tablets; Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-12561-04
Sep 2, 2027
ThorminMetformin Hydrochloride
850 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
ST. RAPHAEL ARCHANGEL PHARMACEUTICAL PRODUCT DISTRIBUTIONTrader: Eba Generisch Trading Inc.
DRP-14255-03
Sep 12, 2031
UnbrandedMetformin Hydrochloride
500 mg Extended-Release TabletAlu-Alu blister pack x 10's (Box of 30's)
RxVAT-exempt
Torrent Pharmaceuticals, Ltd.India
TGP Pharma, Inc.Importer: Torrent Pharma Philippines, Inc.
DRP-2445-03
Oct 20, 2031
UnbrandedMetformin (as Hydrochloride)
500 mg Film-Coated TabletAlu-PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Bulacan
Trader: Dyna Drug Corporation
DR-XY40446
Dec 23, 2036
UnbrandedMetformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Rizal
—
DR-XY45739
Jan 12, 2037
UnbrandedMetformin hydrochloride
500 mg Film-Coated TabletAlu-Clear PVDC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
—
DR-XY46995
Aug 7, 2030
UnbrandedMetformin Hydrochloride
500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Sydenham Laboratories, Inc.Philippines
—
DRP-3156
Aug 17, 2031
UnbrandedMetformin Hydrochloride
500 mg Film-Coated Tablet
RxVAT-exempt
Hizon Laboratories, Inc.
—
DRP-7406
Jan 12, 2027
UnbrandedMetformin Hydrochloride
500 mg TabletAlu/PVC Blister Pack x 10's Box of 100's
RxVAT-exempt
Medico Remedies LimitedIndia
Vivilon Pharmaceuticals Inc.Importer: I.E. Medica, Inc.
DRP-5363-02
Jun 26, 2029
UnbrandedMetformin Hydrochloride
500mg Extended-Released TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Bafna Pharmaceutricals LimitedIndia
Medethix, Inc.
DRP-15011
Mar 13, 2031
UnbrandedMetformin Hydrochloride
850 mg Film-Coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Sydenham Laboratories, Inc.Philippines
—
DRP-3292
Oct 3, 2031
VimetrolMetformin (as Hydrochloride)
500 mg Film-Coated TabletAlu-PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Bulacan
Ultramed Pharma, Inc.Trader: Vamsler Phils. Incorporated
DR-XY40444
Dec 23, 2031
Xmet ER 500Metformin Hydrochloride
500 mg Extended-Release TabletAlu/PVC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Glenmark Pharmaceuticals Ltd.India
Glenmark Philippines, Inc.
DRP-8470
Jan 26, 2032
XometMetformin hydrochloride
500mg Film-Coated TabletAlu-PVC/PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises Inc.
DRP-14888
Jan 31, 2029
Xrmin ER 1000.Metformin Hydrochloride
1 g Extended-Release TabletAlu-PVC/PVDC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Exemed PharmaceuticalsIndia
Ambica International Corporation
DRP-15791
Sep 18, 2029
Xrmin ER 500Metformin Hydrochloride
500 mg Extended-Release TabletAlu-PVC/PVDC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Exemed PharmaceuticalsIndia
Ambica International Corporation
DRP-15790
Sep 18, 2029
(no brand name)Metformin (as hydrochloride)
1 g Extended Release TabletAlu/Clear PVC-PVdC Blister Pack x 10's (Box of 60's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
—
DRP-17327
Nov 14, 2030
(no brand name)Metformin hydrochloride
1 g Extended-Release TabletAluminum blister foil strip with Alcar thermoforming film x 10' s (Box of 100' s)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, INC.
DR-XY48798
Jun 30, 2028
(no brand name)Metformin Hydrochloride
1 g Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10 blister packs x 10 tablets)
RxVAT-exempt
United International Pharma Co. Ltd.Vietnam
RiteMED Phils., Inc.Trader: Concord Pharmaceutical Limited
DRP-12989
Nov 16, 2027
(no brand name)Metformin Hydrochloride
1 g Prolonged-Release TabletAlu/Clear PVC/PVDC Blister Pack x 14's (Box of 28's)
RxVAT-exempt
Ind-Swift LimitedIndia
RiteMED Phils., Inc.
DRP-13780
Apr 18, 2028
(no brand name)Metformin hydrochloride
500 mg Extended-Release TabletAlu/Clear PVC/PVDC Blister Pack x 10's (Box of 60's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
—
DRP-17477
Jan 8, 2031
(no brand name)Metformin Hydrochloride
500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Centurica Laboratories Pvt. Ltd.India
Watsons Personal Care Stores (Philippines), Inc.Importer: Philgen Pharmaceuticals Inc.
DRP-4077-04
Jun 24, 2027
(no brand name)Metformin Hydrochloride
500 mg TabletAlu/Alu Blister Strip x 10's (Box of 100's)
RxVAT-exempt
United International Pharma Co. Ltd.Vietnam
Ritemed Phils., Inc.
DRP-12246
Jul 11, 2027
(no brand name)Metformin hydrochloride
750 mg Extended-Release TabletAlu/Clear PVC/PVDC Blister Pack x 10's (Box of 60's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
—
DRP-17478
Jan 8, 2031

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

United States (label)

Dosage forms and strengths (US label) US FDA label

3 DOSAGE FORMS AND STRENGTHS Metformin Hydrochloride Tablets, USP are available as: Metformin Hydrochloride Tablets, USP 500 mg are blackberry flavored, white to off-white, round, biconvex, beveled edge film coated tablets, debossed with ‘SG’ on one side ‘105’ on other side. Metformin Hydrochloride Tablets, USP 625 mg are blackberry flavored, White to off-white, modified capsule shape film coated tablets, debossed with ‘588’ on one side.

Metformin Hydrochloride Tablets, USP 750 mg are blackberry flavored, White to off-white, modified capsule shape film coated tablets, debossed with ‘589’ on one side. Metformin Hydrochloride Tablets, USP 850 mg are blackberry flavored, white to off-white, round, biconvex, beveled edge film coated tablets, debossed with ‘SG’ on one side ‘106’ on other side.

Metformin Hydrochloride Tablets, USP 1000 mg tablets are blackberry flavored, white to off-white, oval, biconvex, film coated tablets debossed on one side with S on the left side of bisect and G on the right side of bisect and other side 1 on the left side and 07 on the right side of the bisect. Metformin Hydrochloride Tablets, USP: 500 mg, 625 mg, 750 mg, 850 mg, and 1000 mg (3)

Warnings/Precautions

The boxed warning is shown at the top of this page.

Warnings and precautions (US label) US FDA label
  • Lactic Acidosis: See boxed warning. (5.1)
  • Vitamin B12 Deficiency: Metformin may lower vitamin B12 levels. Measure hematological parameters annually and vitamin B12 at 2 to 3 year intervals and manage any abnormalities. (5.2)
  • Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues: Increased risk of hypoglycemia when used in combination with insulin and/or an insulin secretagogue. Lower dose of insulin or insulin secretagogue may be required (5.3)
5.1 Lactic Acidosis

5.1 Lactic Acidosis There have been postmarketing cases of metformin-associated lactic acidosis, including fatal cases. These cases had a subtle onset and were accompanied by nonspecific symptoms such as malaise, myalgias, abdominal pain, respiratory distress, or increased somnolence; however, hypotension and resistant bradyarrhythmias have occurred with severe acidosis.

Metformin associated lactic acidosis was characterized by elevated blood lactate concentrations (>5 mmol/L), anion gap acidosis (without evidence of ketonuria or ketonemia), and an increased lactate: pyruvate ratio; metformin plasma levels were generally >5 mcg/mL. Metformin decreases liver uptake of lactate increasing lactate blood levels which may increase the risk of lactic acidosis, especially in patients at risk.

If metformin-associated lactic acidosis is suspected, general supportive measures should be instituted promptly in a hospital setting, along with immediate discontinuation of Metformin Hydrochloride. In Metformin Hydrochloride Tablets treated patients with a diagnosis or strong suspicion of lactic acidosis, prompt hemodialysis is recommended to correct the acidosis and remove accumulated metformin (metformin hydrochloride is dialyzable with a clearance of up to 170 mL/min under good hemodynamic conditions).

Hemodialysis has often resulted in reversal of symptoms and recovery. Educate patients and their families about the symptoms of lactic acidosis and, if these symptoms occur, instruct them to discontinue Metformin Hydrochloride Tablets and report these symptoms to their healthcare provider. For each of the known and possible risk factors for metformin-associated lactic acidosis, recommendations to reduce the risk of and manage metformin-associated lactic acidosis are provided below: Renal impairment— The postmarketing metformin-associated lactic acidosis cases primarily occurred in patients with significant renal impairment.

The risk of metformin accumulation and metformin-associated lactic acidosis increases with the severity of renal impairment because metformin is substantially excreted by the kidney. Clinical recommendations based upon the patient’s renal function include [see Dosage and Administration (2.1), Clinical Pharmacology (12.3)]: Before initiating Metformin Hydrochloride, obtain an estimated glomerular filtration rate (eGFR).

Metformin Hydrochloride is contraindicated in patients with an eGFR less than 30 mL/min/1.73 m² [see Contraindications (4)]. Initiation of Metformin Hydrochloride is not recommended in patients with eGFR between 30-45 mL/min/1.73 m². Obtain an eGFR at least annually in all patients taking Metformin Hydrochloride. In patients at risk for the development of renal impairment (e.g., the elderly), renal function should be assessed more frequently.

In patients taking Metformin Hydrochloride whose eGFR falls below 45 mL/min/1.73 m², assess the benefit and risk of continuing therapy.

Drug interactions — The concomitant use of Metformin Hydrochloride with specific drugs may increase the risk of metformin-associated lactic acidosis: those that impair renal function, result in significant hemodynamic change, interfere with acid-base balance, or increase metformin accumulation. Consider more frequent monitoring of patients.

Age 65 or greater — The risk of metformin-associated lactic acidosis increases with the patient’s age because elderly patients have a greater likelihood of having hepatic, renal, or cardiac impairment than younger patients. Assess renal function more frequently in elderly patients.

Radiologic studies with contrast — Administration of intravascular iodinated contrast agents in metformin-treated patients has led to an acute decrease in renal function and the occurrence of lactic acidosis. Stop Metformin Hydrochloride at the time of, or prior to, an iodinated contrast imaging procedure in patients with an eGFR between 30 and 60 mL/min/1.73 m²; in patients with a history of hepatic impairment, alcoholism or heart failure; or in patients who will be administered intra-arterial iodinated contrast.

Re-evaluate eGFR 48 hours after the imaging procedure, and restart Metformin Hydrochloride if renal function is stable.

Surgery and other procedures — Withholding of food and fluids during surgical or other procedures may increase the risk for volume depletion, hypotension, and renal impairment. Metformin Hydrochloride should be temporarily discontinued while patients have restricted food and fluid intake.

Hypoxic states — Several of the postmarketing cases of metformin-associated lactic acidosis occurred in the setting of acute congestive heart failure (particularly when accompanied by hypoperfusion and hypoxemia). Cardiovascular collapse (shock), acute myocardial infarction, sepsis, and other conditions associated with hypoxemia have been associated with lactic acidosis and may cause prerenal azotemia.

When such an event occurs, discontinue Metformin Hydrochloride Tablets.

Excessive alcohol intake — Alcohol potentiates the effect of metformin on lactate metabolism. Patients should be warned against excessive alcohol intake while receiving Metformin Hydrochloride Tablets.

Hepatic impairment — Patients with hepatic impairment have developed cases of metformin-associated lactic acidosis. This may be due to impaired lactate clearance resulting in higher lactate blood levels. Therefore, avoid use of Metformin Hydrochloride Tablets in patients with clinical or laboratory evidence of hepatic disease.

Mitochondrial Diseases — Metformin may increase the risk of lactic acidosis in patients with mitochondrial diseases such as mitochondrial encephalomyopathy with lactic acidosis, and stroke-like episodes (MELAS) syndrome and maternally inherited diabetes and deafness (MIDD). Metformin Hydrochloride Tablets are not recommended in patients with mitochondrial diseases such as MELAS syndrome and MIDD.

If a patient taking Metformin Hydrochloride Tablets develops elevated lactic acid levels (with or without accompanying neurologic signs and symptoms), discontinue Metformin Hydrochloride Tablets. Depending on the clinical context, consider evaluating the patient for MELAS, MIDD, or other mitochondrial disease.

5.2 Vitamin B12 Deficiency

5.2 Vitamin B12 Deficiency In Metformin Hydrochloride clinical trials of 29-week duration, a decrease to subnormal levels of previously normal serum vitamin B12 levels was observed in approximately 7% of patients. Such decrease, possibly due to interference with B12 absorption from the B12 -intrinsic factor complex, may be associated with anemia but appears to be rapidly reversible with discontinuation of Metformin Hydrochloride or vitamin B12 supplementation.

Certain individuals (those with inadequate vitamin B12 or calcium intake or absorption) appear to be predisposed to developing subnormal vitamin B12 levels. Measure hematologic parameters on an annual basis and vitamin B12 at 2 to 3 year intervals in patients on Metformin Hydrochloride and manage any abnormalities [see Adverse Reactions (6.1)].

5.3 Hypoglycemia with Concomitant Use with Insulin

5.3 Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues Insulin and insulin secretagogues (e.g., sulfonylurea) are known to cause hypoglycemia. Metformin Hydrochloride tablets may increase the risk of hypoglycemia when combined with insulin and/or an insulin secretagogue. Therefore, a lower dose of insulin or insulin secretagogue may be required to minimize the risk of hypoglycemia when used in combination with Metformin Hydrochloride Tablets [see Drug Interactions (7)].

5.4 Macrovascular Outcomes

5.4 Macrovascular Outcomes There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with Metformin Hydrochloride Tablets.

Drug interactions

Drug or classSeverityEffectWhat to do
Carbonic anhydrase inhibitors (topiramate, zonisamide, acetazolamide)Adjust or monitorLower bicarbonate; higher lactic acidosis risk.Consider more frequent monitoring.
OCT2/MATE inhibitors (ranolazine, vandetanib, dolutegravir, cimetidine)Adjust or monitorHigher metformin exposure; lactic acidosis risk.Weigh benefits and risks of the combination.
Iodinated contrastAdjust or monitorContrast-related kidney injury can lead to metformin accumulation and lactic acidosis.May need to stop metformin around the procedure (see label 2.3).
AlcoholAdjust or monitorPotentiates metformin's effect on lactate.Warn against excessive alcohol.
Insulin or insulin secretagoguesAdjust or monitorMore hypoglycemia.Lower insulin or secretagogue doses may be needed.
Drugs that raise glucose (thiazides, corticosteroids, others)MinorLoss of glycemic control.Watch glucose when starting or stopping them.

Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.

renalcarematters.com, reviewed
Drug interactions (US label) US FDA label

7 DRUG INTERACTIONS Table 3 presents clinically significant drug interactions with Metformin Hydrochloride tablets. Table 3: Clinically Significant Drug Interactions with Metformin Hydrochloride Tablets Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis.

Concomitant use of these drugs with Metformin Hydrochloride may increase the risk for lactic acidosis. Intervention: Consider more frequent monitoring of these patients. Examples: Topiramate, zonisamide, acetazolamide or dichlorphenamide. Drugs that Reduce Metformin Hydrochloride Clearance Clinical Impact: Concomitant use of drugs that interfere with common renal tubular transport systems involved in the renal elimination of metformin (e.g., organic cationic transporter-2 [OCT2] / multidrug and toxin extrusion [MATE] inhibitors) could increase systemic exposure to metformin and may increase the risk for lactic acidosis [Clinical Pharmacology (12.3)].

Intervention: Consider the benefits and risks of concomitant use with Metformin Hydrochloride. Examples: Ranolazine, vandetanib, dolutegravir, and cimetidine. Alcohol Clinical Impact: Alcohol is known to potentiate the effect of metformin on lactate metabolism. Intervention: Warn patients against excessive alcohol intake while receiving Metformin Hydrochloride.

Insulin Secretagogues or Insulin Clinical Impact: Coadministration of Metformin Hydrochloride with an insulin secretagogue (e.g., sulfonylurea) or insulin may increase the risk of hypoglycemia. Intervention: Patients receiving an insulin secretagogue or insulin may require lower doses of the insulin secretagogue or insulin.

Drugs Affecting Glycemic Control Clinical Impact: Certain drugs tend to produce hyperglycemia and may lead to loss of glycemic control. Intervention: When such drugs are administered to a patient receiving Metformin Hydrochloride, observe the patient closely for loss of blood glucose control. When such drugs are withdrawn from a patient receiving Metformin Hydrochloride tablets, observe the patient closely for hypoglycemia.

Examples: Thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, and isoniazid. Carbonic anhydrase inhibitors may increase risk of lactic acidosis. Consider more frequent monitoring (7) Drugs that reduce metformin clearance (such as ranolazine, vandetanib, dolutegravir, and cimetidine) may increase the accumulation of metformin.

Consider the benefits and risks of concomitant use (7) Alcohol can potentiate the effect of metformin on lactate metabolism. Warn patients against excessive alcohol intake (7)

Metabolism and transporters (CYP, P-gp, OATP; US label) US FDA label

Drugs that Reduce Metformin Hydrochloride Clearance Clinical Impact: Concomitant use of drugs that interfere with common renal tubular transport systems involved in the renal elimination of metformin (e.g., organic cationic transporter-2 [OCT2] / multidrug and toxin extrusion [MATE] inhibitors) could increase systemic exposure to metformin and may increase the risk for lactic acidosis [ Clinical Pharmacology (12.3) ].

Adverse reactions

Common

  • Diarrhea (53% vs 12% placebo)
  • Nausea or vomiting (26% vs 8%)
  • Flatulence (12% vs 6%)
  • Asthenia (9% vs 6%)
  • Indigestion (7%), abdominal discomfort (6%), headache (6%)
  • Subnormal vitamin B12 (about 7% in 29-week trials)

Serious

  • Lactic acidosis, sometimes fatal (boxed warning)
  • Vitamin B12 deficiency
  • Hypoglycemia with insulin or insulin secretagogues
renalcarematters.com, reviewed
Adverse reactions (US label) US FDA label
  • The following adverse reactions are also discussed elsewhere in the labeling: Lactic Acidosis [see Boxed Warning and Warnings and Precautions (5.1)] Vitamin B12 Deficiency [see Warnings and Precautions (5.2)] Hypoglycemia [see Warnings and Precautions (5.3)] For Metformin Hydrochloride Tablets, the most common adverse reactions (>5.0%) are diarrhea, nausea/vomiting, flatulence, asthenia, indigestion, abdominal discomfort, and headache. (6.1)
  • To report SUSPECTED ADVERSE REACTIONS, contact ScieGen at (855) 724-3436 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
6.1 Clinical Studies Experience

6.1 Clinical Studies Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. Metformin Hydrochloride Tablets In a U.S. clinical trial of Metformin Hydrochloride in patients with type 2 diabetes mellitus, a total of 141 patients received Metformin Hydrochloride up to 2550 mg per day.

Adverse reactions reported in greater than 5% of Metformin Hydrochloride treated patients and that were more common than in placebo-treated patients, are listed in Table 1. Table 1: Adverse Reactions from a Clinical Trial of Metformin Hydrochloride Occurring >5% and More Common than Placebo in Patients with Type 2 Diabetes Mellitus Metformin Hydrochloride (n=141) Placebo (n=145) Diarrhea 53% 12% Nausea/Vomiting 26% 8% Flatulence 12% 6% Asthenia 9% 6% Indigestion 7% 4% Abdominal Discomfort 6% 5% Headache 6% 5% Diarrhea led to discontinuation of Metformin Hydrochloride in 6% of patients.

Additionally, the following adverse reactions were reported in ≥1% to ≤5% of Metformin Hydrochloride treated patients and were more commonly reported with Metformin Hydrochloride than placebo: abnormal stools, hypoglycemia, myalgia, lightheaded, dyspnea, nail disorder, rash, sweating increased, taste disorder, chest discomfort, chills, flu syndrome, flushing, palpitation. In Metformin Hydrochloride clinical trials of 29-week duration, a decrease to subnormal levels of previously normal serum vitamin B12 levels was observed in approximately 7% of patients.

Pediatric Patients In clinical trials with Metformin Hydrochloride Tablets in pediatric patients with type 2 diabetes mellitus, the profile of adverse reactions was similar to that observed in adults.

6.2 Postmarketing Experience

6.2 Postmarketing Experience The following adverse reactions have been identified during post approval use of metformin. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Cholestatic, hepatocellular, and mixed hepatocellular liver injury have been reported with postmarketing use of metformin.

Adverse reaction frequency tables (US label) US FDA label
Table 1: Adverse Reactions from a Clinical Trial of Metformin Hydrochloride Occurring >5% and More Common than Placebo in Patients with Type 2 Diabetes Mellitus
Metformin Hydrochloride (n=141) Placebo (n=145)
Diarrhea 53% 12%
Nausea/Vomiting 26% 8%
Flatulence 12% 6%
Asthenia 9% 6%
Indigestion 7% 4%
Abdominal Discomfort 6% 5%
Headache 6% 5%

Monitoring parameters

  • eGFR before starting and at least periodically; more often in older adults. Stop before or at the time of iodinated contrast in at-risk patients per label. Hold temporarily during acute illness with dehydration, sepsis, hypoxia or acute heart failure, during procedures with restricted food or fluid intake, and for acute kidney injury; restart when eating and kidney function is stable (label 5.1). Kidney
  • eGFR before starting and periodically (at least yearly; more often if at risk)
  • Hematologic parameters yearly and vitamin B12 every 2 to 3 years (label 5.2)
  • Hold for iodinated contrast per eGFR rules; recheck eGFR 48 hours after the procedure (label 2.4)
  • Glycemic control
  • Hold temporarily during acute illness with dehydration, sepsis, hypoxia or acute heart failure, during procedures with restricted food or fluid intake, and for acute kidney injury; restart when eating and kidney function is stable (label 5.1).
renalcarematters.com, reviewed

Pregnancy considerations

Pregnancy (US label) US FDA label

8.1 Pregnancy Risk Summary Limited data with Metformin Hydrochloride in pregnant women are not sufficient to determine a drug-associated risk for major birth defects or miscarriage. Published studies with metformin use during pregnancy have not reported a clear association with metformin and major birth defect or miscarriage risk [see Data].

There are risks to the mother and fetus associated with poorly controlled diabetes mellitus in pregnancy [see Clinical Considerations]. No adverse developmental effects were observed when metformin was administered to pregnant Sprague Dawley rats and rabbits during the period of organogenesis at doses up to 2-and 5times, respectively, a 2550 mg clinical dose, based on body surface area [see Data].

The estimated background risk of major birth defects is 6–10% in women with pre-gestational diabetes mellitus with an HbA1C >7 and has been reported to be as high as 20–25% in women with a HbA1C >10. The estimated background risk of miscarriage for the indicated population is unknown. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2–4% and 15–20%, respectively.

Clinical Considerations Disease-associated maternal and/or embryo/fetal risk Poorly-controlled diabetes mellitus in pregnancy increases the maternal risk for diabetic ketoacidosis, pre-eclampsia, spontaneous abortions, preterm delivery, stillbirth and delivery complications. Poorly controlled diabetes mellitus increases the fetal risk for major birth defects, stillbirth, and macrosomia related morbidity.

Data Human Data Published data from post-marketing studies have not reported a clear association with metformin and major birth defects, miscarriage, or adverse maternal or fetal outcomes when metformin was used during pregnancy. However, these studies cannot definitely establish the absence of any metformin-associated risk because of methodological limitations, including small sample size and inconsistent comparator groups.

Animal Data Metformin hydrochloride did not adversely affect development outcomes when administered to pregnant rats and rabbits at doses up to 600 mg/kg/day. This represents an exposure of about 2 and 5 times a 2550 mg clinical dose based on body surface area comparisons for rats and rabbits, respectively. Determination of fetal concentrations demonstrated a partial placental barrier to metformin.

Mechanism of action

12.1 Mechanism of Action Metformin is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes mellitus, lowering both basal and postprandial plasma glucose. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and day-long plasma insulin response may decrease.

US FDA label

Pharmacokinetics

Key PK parameters

BioavailabilityAbout 50% to 60% (500 mg tablet, fasting); food lowers it slightly
Time to peakAbout 2 to 3 hours (immediate-release; Tmax 1.8 to 3.3 hours in label Table 4)
Half-lifeAbout 6.2 hours in plasma; about 17.6 hours in blood
Half-life in kidney failure (ESKD) kidneyProlonged; not quantified in the label. Renal clearance about 108 to 130 mL/min at CLcr 10 to 60 vs about 550 to 640 mL/min in healthy adults (label Table 4)
Volume of distribution654 ± 358 L (V/F, 850 mg metformin HCl)
Protein bindingNegligible
Metabolism (CYP, transporters)None (not metabolized)
Active metabolitesNone
Renal excretion kidneyAbout 90% of absorbed drug renally within 24 hours (tubular secretion; renal clearance about 3.5 times CrCl)
Dialyzability kidneyYes: clearance up to 170 mL/min under good hemodynamic conditions (label).
renalcarematters.com, reviewed
Half-life and elimination (verbatim, US label)

Metabolism Intravenous single-dose studies in normal subjects demonstrate that metformin is excreted unchanged in the urine and does not undergo hepatic metabolism (no metabolites have been identified in humans) nor biliary excretion.

Elimination Renal clearance (see Table 4) is approximately 3.5 times greater than creatinine clearance, which indicates that tubular secretion is the major route of metformin elimination.

Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.

In blood, the elimination half-life is approximately 17.6 hours, suggesting that the erythrocyte mass may be a compartment of distribution.

Specific Populations Renal Impairment In patients with decreased renal function the plasma and blood half-life of metformin is prolonged and the renal clearance is decreased (see Table 3) [ See Dosage and Administration (2.3) , Contraindications (4) , Warnings and Precautions (5.1) and Use in Specific Populations (8.6) ] .

Pharmacokinetics (US label) US FDA label

12.3 Pharmacokinetics Absorption The absolute bioavailability of a metformin hydrochloride 500 mg tablet given under fasting conditions is approximately 50% to 60%. Studies using single oral doses of metformin hydrochloride 500 to 1500 mg and 850 to 2550 mg, indicate that there is a lack of dose proportionality with increasing doses, which is due to decreased absorption rather than an alteration in elimination.

At usual clinical doses and dosing schedules of metformin hydrochloride, steady state plasma concentrations of metformin are reached within 24 to 48 hours and are generally <1 μg/mL. Effect of food: Food decreases the extent of absorption and slightly delays the absorption of metformin, as shown by approximately a 40% lower mean peak plasma concentration (C max), a 25% lower area under the plasma concentration versus time curve (AUC), and a 35-minute prolongation of time to peak plasma concentration (T max) following administration of a single 850 mg tablet of Metformin Hydrochloride with food, compared to the same tablet strength administered fasting.

Distribution The apparent volume of distribution (V/F) of metformin following single oral doses of Metformin Hydrochloride 850 mg averaged 654 ± 358 L. Metformin is negligibly bound to plasma proteins. Metformin partitions into erythrocytes, most likely as a function of time. Metabolism Intravenous single-dose studies in normal subjects demonstrate that metformin is excreted unchanged in the urine and does not undergo hepatic metabolism (no metabolites have been identified in humans) nor biliary excretion.

Elimination Renal clearance (see Table 4) is approximately 3.5 times greater than creatinine clearance, which indicates that tubular secretion is the major route of metformin elimination. Following oral administration, approximately 90% of the absorbed drug is eliminated via the renal route within the first 24 hours, with a plasma elimination half-life of approximately 6.2 hours.

In blood, the elimination half-life is approximately 17.6 hours, suggesting that the erythrocyte mass may be a compartment of distribution. Specific Populations Renal Impairment In patients with decreased renal function the plasma and blood half-life of metformin is prolonged and the renal clearance is decreased (see Table 3) [See Dosage and Administration (2.3), Contraindications (4), Warnings and Precautions (5.1) and Use in Specific Populations (8.6)].

Hepatic Impairment No pharmacokinetic studies of metformin have been conducted in patients with hepatic impairment [See Warnings and Precautions (5.1) and Use in Specific Populations (8.7)]. Geriatrics Limited data from controlled pharmacokinetic studies of metformin hydrochloride in healthy elderly subjects suggest that total plasma clearance of metformin is decreased, the half-life is prolonged, and C max is increased, compared to healthy young subjects.

It appears that the change in metformin pharmacokinetics with aging is primarily accounted for by a change in renal function (see Table 4). [See Warnings and Precautions (5.1) and Use in Specific Populations (8.5)]. Table 4: Select Mean (±S.D.) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin Hydrochloride Tablets a All doses given fasting except the first 18 doses of the multiple dose studies b Peak plasma concentration c Time to peak plasma concentration d Combined results (average means) of five studies: mean age 32 years (range 23-59 years) e Kinetic study done following dose 19, given fasting f Elderly subjects, mean age 71 years (range 65-81 years) g CLcr = creatinine clearance normalized to body surface area of 1.73 m² Subject Groups: Metformin hydrochloride tablets dose a (number of subjects) C max b (mcg/mL) T max c (hrs) Renal Clearance (mL/min) Healthy, nondiabetic adults: 500 mg single dose (24) 850 mg single dose (74) d 850 mg three times daily for 19 doses e (9) 1.03 (±0.33) 1.60 (±0.38) 2.01 (±0.42) 2.75 (±0.81) 2.64 (±0.82) 1.79 (±0.94) 600 (±132) 552 (±139) 642 (±173) Adults with type 2 diabetes mellitus: 850 mg single dose (23) 850 mg three times daily for 19 doses e (9) 1.48 (±0.5) 1.90 (±0.62) 3.32 (±1.08) 2.01 (±1.22) 491 (±138) 550 (±160) Elderly f, healthy nondiabetic adults: 850 mg single dose (12) 2.45 (±0.70) 2.71 (±1.05) 412 (±98) Renal-impaired adults: 850 mg single dose Mild (CLcr g 61 to 90 mL/min) (5) Moderate (CLcr 31 to 60 mL/min) (4) Severe (CLcr 10 to 30 mL/min) (6) 1.86 (±0.52) 4.12 (±1.83) 3.93 (±0.92) 3.20 (±0.45) 3.75 (±0.50) 4.01 (±1.10) 384 (±122) 108 (±57) 130 (±90) Pediatrics After administration of a single oral metformin hydrochloride 500 mg tablet with food, geometric mean metformin C max and AUC differed less than 5% between pediatric type 2 diabetic patients (12-16 years of age) and gender-and weight-matched healthy adults (20-45 years of age), all with normal renal function.

Gender Metformin pharmacokinetic parameters did not differ significantly between normal subjects and patients with type 2 diabetes mellitus when analyzed according to gender (males=19, females=16). Race No studies of metformin pharmacokinetic parameters according to race have been performed. Drug Interactions In Vivo Assessment of Drug Interactions Table 5: Effect of Coadministered Drug on Plasma Metformin Systemic Exposure Coadministered Drug Dose of Coadministered Drug * Dose of Metformin * Geometric Mean Ratio (ratio with/without coadministered drug) No Effect = 1.00 AUC † C max No dosing adjustments required for the following: Glyburide 5 mg 850 mg metformin 0.91 ‡ 0.93 ‡ Furosemide 40 mg 850 mg metformin 1.09 ‡ 1.22 ‡ Nifedipine 10 mg 850 mg metformin 1.16 1.21 Propranolol 40 mg 850 mg metformin 0.90 0.94 Ibuprofen 400 mg 850 mg metformin 1.05 ‡ 1.07 ‡ Cationic drugs eliminated by renal tubular secretion may reduce metformin elimination Cimetidine 400 mg 850 mg metformin 1.40 1.61 Carbonic anhydrase inhibitors may cause metabolic acidosis [See Warnings and Precautions (5.1) and Drug Interactions (7).] Topiramate 100 mg § 500 mg § metformin 1.25 § 1.07 * All metformin and coadministered drugs were given as single doses † AUC = AUC(INF) ‡ Ratio of arithmetic means § At steady state with topiramate 100 mg every 12 hours and metformin 500 mg every 12 hours; AUC = AUC 0-12h Table 6: Effect of Metformin on Coadministered Drug Systemic Exposure Coadministered Drug Dose of Coadministered Drug * Dose of Metformin * Geometric Mean Ratio (ratio with/without metformin) No Effect = 1.00 AUC † C max No dosing adjustments required for the following: Glyburide 5 mg 850 mg glyburide 0.78 ‡ 0.63 ‡ Furosemide 40 mg 850 mg furosemide 0.87 ‡ 0.69 ‡ Nifedipine 10 mg 850 mg nifedipine 1.10 § 1.08 Propranolol 40 mg 850 mg propranolol 1.01 § 1.02 Ibuprofen 400 mg 850 mg ibuprofen 0.97 ¶ 1.01 ¶ Cimetidine 400 mg 850 mg cimetidine 0.95 § 1.01 * All metformin and coadministered drugs were given as single doses † AUC = AUC(INF) unless otherwise noted ‡ Ratio of arithmetic means, p-value of difference <0.05 § AUC(0-24 hr) reported ¶ Ratio of arithmetic means

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Metformin Hydrochloride 500 mg Film coated tablet₱0.43–₱3.85Reference ₱0.54per tabletDPRI procurement range
Metformin Hydrochloride 850 mg Tablet₱4.05–₱4.39Reference ₱4.39per tabletDPRI procurement range
500 mg (as hydrochloride) film-coated tablet₱4.75per tabletPhilHealth GAMOT fixed fee
500 mg (as hydrochloride) tablet₱4.75per tabletPhilHealth GAMOT fixed fee
850 mg (as hydrochloride) tablet₱5.25per tabletPhilHealth GAMOT fixed fee

PhilHealth GAMOT fixed fee paid to the accredited GAMOT pharmacy per unit dispensed Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Metformin (as hydrochloride)
PNF listingOral: 500 mg tablet/film coated tablet 850 mg tablet
PhilHealth GAMOTYes (listed since July 28, 2025)
PhilHealth YAKAP (formerly Konsulta)Yes

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. METFORMIN HYDROCHLORIDE · ScieGen Pharmaceuticals Inc [US FDA-approved label, version 10, August 21, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e4c4ba9-65c6-4273-8f6b-2423ab521dad
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  4. PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
  5. PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
  6. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
  7. ScieGen Pharmaceuticals Inc. (2026). Metformin hydrochloride tablets (metformin hydrochloride; immediate release) [Prescribing information; US FDA-approved label, ANDA203769, set ID 4e4c4ba9-65c6-4273-8f6b-2423ab521dad, version effective August 21, 2026]. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e4c4ba9-65c6-4273-8f6b-2423ab521dad
  8. de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, P., & Bakris, G. (2022). Diabetes management in chronic kidney disease: A consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care, 45(12), 3075–3090. https://doi.org/10.2337/dci22-0027
  9. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. (2022). KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney International, 102(5S), S1–S127. https://doi.org/10.1016/j.kint.2022.06.008
  10. Santarus, Inc. (2026). Glumetza (metformin hydrochloride extended-release tablets) [Prescribing information; US FDA-approved label, NDA021748, set ID fb832474-88d9-4e29-95cd-fbc446944cc4, version effective September 2, 2026]. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb832474-88d9-4e29-95cd-fbc446944cc4
  11. Schwartz, G. J., Muñoz, A., Schneider, M. F., Mak, R. H., Kaskel, F., Warady, B. A., & Furth, S. L. (2009). New equations to estimate GFR in children with CKD. Journal of the American Society of Nephrology, 20(3), 629–637. https://doi.org/10.1681/ASN.2008030287

renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 16, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 16, 2026.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .